Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Chemours Co (CC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/01/2023 8-K Quarterly results
07/26/2023 8-K Quarterly results
06/30/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
06/02/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems"
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million WILMINGTON, Del., NASHVILLE, Tn, June 1, 2023 -- The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials has entered into a definitive agreement to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle market investments across the specialty industrial and healthcare sectors. With this acquisition, PureTech Scientific is positioning itself to become the global leader in organic synthesis of ultra-high purity alpha..."
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Chemours Thermal & Specialized Solutions President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader"
04/27/2023 8-K Quarterly results
04/27/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Chemours Appoints Denise Dignam President, Titanium Technologies & Chemical Solutions, Gerardo Familiar Named President, Advanced Performance Materials Business strategies are unchanged as the company promotes top executives Wilmington, Del., March 23, 2023 – The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announces the appointment of Denise Dignam as President, Chemours Titanium Technologies and Chemical Solutions, effective April 1, 2023. Chemours will promote Gerardo Familiar to succeed Ms. Dignam as President, Chemours Advanced Performance Materials. “Chemours is fortunate to have tremendous internal talent from which to draw in order to fill these key l..."
03/15/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "EACH PARTY HERETO HEREBY AGREES AS SET FORTH IN SECTIONS 9.09, 9.09, 9.09 AND 9.10 OF THE CREDIT AGREEMENT AS IF SUCH SECTIONS WERE SET FORTH IN FULL HEREIN MUTATIS MUTANDIS. 4 SECTION 7. Counterparts; Amendment. This Amendment may be executed in two or more counterparts, each of which shall constitute an original but all of which when taken together shall constitute a single contract. The words “execution”, “signed”, “signature”, “delivery” and words of like import in or relating to this Amendment and/or any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include Electronic Signatures , deliveries or the keeping of records in electronic form, each of which shall be o..."
02/09/2023 8-K Quarterly results
Docs: "The Chemours Company Reports Fourth Quarter and Full Year 2022 Results, Provides Full Year 2023 Outlook Delivered record annual results in TSS and APM driven by strong secular tailwinds Wilmington, Del., February 9, 2023 -- The Chemours Company , a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials today announced its financial results for the fourth quarter and full year 2022. Full Year 2022 Results • Net Sales of $6.8 billion, up 7% year-over-year • Net Income of $578 million with EPS1 of $3.65, up $0.05 year-over-year • Adjusted Net Income* of $738 million with Adjusted EPS* of $4.66, up $0.66 year-over-year • Adjusted EBITDA*of $1,361 million, up 4% year-over-ye..."
12/22/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
10/25/2022 8-K Quarterly results
09/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "The Chemours Company Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures 2022 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income, Estimated Adjusted EBITDA and Estimated Adjusted EPS Reconciliation Adjusted earnings before interest, taxes, depreciation, and amortization is defined as income before income taxes, excluding the following items: interest expense, depreciation, and amortization; non-operating pension and other post-retirement employee benefit costs, which represents the components of net periodic pension costs excluding the service cost component; exchange losses included in other income , net; restructuring, asset-related, and other charges; losses on sales of businesses or assets; and, other items not considered indicativ..."
08/22/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
04/29/2022 8-K Quarterly results
03/02/2022 8-K Investor presentation
Docs: "2020 54 46 209 115 2021 266 154 2022 363205 2023 526 268 2024 368 743 2025 513 947 2026 1129 773 2027 1539 975 2028 2244 1326 2029 3590 1928 2030"
02/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook Broad strength despite logistics and pandemic related headwinds – full year 2022 outlook targets continued earnings growth and strong free cash flow generation"
02/09/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/01/2021 8-K Asset disposition
Docs: "Chemours Completes Sale of Mining Solutions Business to Draslovka for $521 Million"
12/01/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECOND AMENDMENT TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT",
"Exhibit A Amendments to the Amended and Restated Receivables Purchase Agreement Exhibit A"
11/04/2021 8-K Quarterly results
Docs: "The Chemours Company Reports Strong Third Quarter Results and Increases Full-Year 2021 Outlook Market strength and operational excellence drove strong quarterly performance, raising outlook as confidence builds"
10/28/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Chemours Names Dawn L. Farrell as Chairperson of its Board of Directors"
10/08/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment No. 1, to the Amended and Restated Credit Agreement, among The Chemours Company, the Lenders and Issuing Banks party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent"
09/29/2021 8-K Quarterly results
09/01/2021 8-K Quarterly results
08/18/2021 8-K Quarterly results
08/04/2021 8-K Quarterly results
07/29/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy